Ciprofloxacin 500Mg Tablet + Doxycycline 100Mg Tablet + AV7909
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Anthrax
Conditions
Anthrax
Trial Timeline
Aug 12, 2019 → Mar 19, 2020
NCT ID
NCT04067011About Ciprofloxacin 500Mg Tablet + Doxycycline 100Mg Tablet + AV7909
Ciprofloxacin 500Mg Tablet + Doxycycline 100Mg Tablet + AV7909 is a phase 2 stage product being developed by Emergent BioSolutions for Anthrax. The current trial status is completed. This product is registered under clinical trial identifier NCT04067011. Target conditions include Anthrax.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04067011 | Phase 2 | Completed |
Competing Products
15 competing products in Anthrax